Matinas BioPharma director Herbert Conrad resigns due to retirement

Matinas BioPharma Holdings, Inc.

Herbert Conrad resigned from Board of Directors effective February 6, 2025.
Conrad also stepped down from Audit and Nominating/Corporate Governance Committees.
Resignation was not due to any material disagreement or change in company direction.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Herbert Conrad

Director

MTNB · Matinas BioPharma Holdings, Inc.

Effective: 2025-02-06
Filed: February 11, 2025, 6:59 PM ET

On February 5, 2025, Herbert Conrad informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning from the Board effective February 6, 2025, due to retirement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Herbert Conrad resigned as Director at Matinas BioPharma Holdings, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 5, 2025, Herbert Conrad informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning from the Board effective February 6, 2025, due to retirement.

View on SEC.gov

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-005948

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.